Cargando…
Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment
The tumor suppressor menin has dual functions, acting either as a tumor suppressor or as an oncogene/oncoprotein, depending on the oncological context. Triple-negative breast cancer (TNBC) is characterized by the lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human...
Autores principales: | Nguyen, Dang Tan, Le, Thi Khanh, Paris, Clément, Cherif, Chaïma, Audebert, Stéphane, Oluchi Udu-Ituma, Sandra, Benizri, Sébastien, Barthélémy, Philippe, Bertucci, François, Taïeb, David, Rocchi, Palma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301388/ https://www.ncbi.nlm.nih.gov/pubmed/34356858 http://dx.doi.org/10.3390/biomedicines9070795 |
Ejemplares similares
-
ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines
por: Udu-Ituma, Sandra, et al.
Publicado: (2023) -
Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity
por: Cherif, Chaïma, et al.
Publicado: (2021) -
Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer
por: Ziouziou, Hajer, et al.
Publicado: (2021) -
Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer
por: Sicard, Guillaume, et al.
Publicado: (2020) -
HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA
por: Bourefis, Asma, et al.
Publicado: (2022)